| Maria Louise Mcdaniel, OTR/L | |
|
6065 S Quebec St Ste 100, Englewood, CO 80111-4575 | |
| (630) 234-4992 | |
| Not Available |
| Full Name | Maria Louise Mcdaniel |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 6065 S Quebec St Ste 100, Englewood, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679197008 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT.0006367 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Louise Mcdaniel, OTR/L 3375 S Washington St, Englewood, CO 80113-2729 Ph: (630) 234-4992 | Maria Louise Mcdaniel, OTR/L 6065 S Quebec St Ste 100, Englewood, CO 80111-4575 Ph: (630) 234-4992 |
News Archive
The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.
"The work of the essential medicines department of the World Health Organization (WHO) is under threat because of a serious shortage of funds, says a worrying and important letter published in the Lancet [on Thursday]," Guardian Health Editor Sarah Boseley reports in her "Global Health Blog."
Research from University of South Carolina associate professor Saurabh Chatterjee's laboratory in Environmental Health Sciences, Arnold School of Public Health, and led by Ayan Mondal, a postdoctoral researcher from the same lab, has revealed the cause behind the previously established link between non-alcoholic fatty liver disease (i.e., NAFLD, recently reclassified as metabolic associated fatty liver disease or MAFLD) and neurological problems.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental New Drug Application (sNDA) seeking approval of DACOGEN (decitabine) for injection in the treatment of acute myeloid leukemia.
› Verified 4 days ago
Whitney Oyster, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 175 Inverness Dr W Ste 200, Englewood, CO 80112 Phone: 303-694-3333 | |
Ms. Gloria Jean Viglione, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 701 E Hampden Ave, Suite 330, Englewood, CO 80113 Phone: 303-497-1724 | |
Miss Kristina Anderson, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 701 E Hampden Ave, Suite 330, Englewood, CO 80113 Phone: 303-806-7421 | |
Lynn Vosbeek, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6065 S Quebec St, Englewood, CO 80111 Phone: 184-442-2266 | |
Kara Greenfield Burks, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 175 Inverness Dr W Ste 100, Englewood, CO 80112 Phone: 303-694-3333 Fax: 303-694-9666 | |
Kerry Goudy, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4480 S Lafayette St, Englewood, CO 80113 Phone: 720-272-2754 | |
Laura Louise Koenig, OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 601 E Hampden Ave Ste 500, Englewood, CO 80113 Phone: 303-744-7078 |